Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amarin Corp Ads (AMRN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,702,768
  • Shares Outstanding, K 322,916
  • Annual Sales, $ 181,100 K
  • Annual Income, $ -67,870 K
  • 36-Month Beta 1.16
  • Price/Sales 24.58
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.08
  • Number of Estimates 2
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.08
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.65 +13.45%
on 02/07/19
18.36 -3.29%
on 02/19/19
+0.52 (+3.05%)
since 01/18/19
3-Month
11.78 +50.72%
on 12/24/18
19.75 -10.10%
on 11/26/18
+0.42 (+2.45%)
since 11/19/18
52-Week
2.35 +655.53%
on 07/31/18
23.33 -23.90%
on 11/06/18
+14.11 (+387.77%)
since 02/16/18

Most Recent Stories

More News
Amarin To Report Fourth Quarter and Full Year 2018 Results and Host Conference Call on February 27, 2019

Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health, today announced that it will host a conference call with members of Amarin senior management to...

AMRN : 17.72 (+0.34%)
What's in the Cards for Amarin (AMRN) This Earnings Season?

Amarin's (AMRN) cardiovascular drug, Vascepa to drive sales in the fourth quarter.

AMRN : 17.72 (+0.34%)
BDSI : 4.86 (+4.97%)
MNK : 21.85 (+0.18%)
TEVA : 17.97 (-0.06%)
Amarin (AMRN) Gains As Market Dips: What You Should Know

Amarin (AMRN) closed at $17.35 in the latest trading session, marking a +1.46% move from the prior day.

AMRN : 17.72 (+0.34%)
Amarin to Present at the 8th Annual SVB Leerink Global Healthcare Conference

Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F. Thero, Amarin's...

AMRN : 17.72 (+0.34%)
Amarin (AMRN) Stock Moves -0.49%: What You Should Know

Amarin (AMRN) closed at $16.15 in the latest trading session, marking a -0.49% move from the prior day.

AMRN : 17.72 (+0.34%)
Analysis: Positioning to Benefit within Amarin, Retrophin, Sunrun, BioSpecifics Technologies, Arbutus Biopharma, and TOCAGEN INC -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Amarin Corporation PLC (NASDAQ:AMRN),...

ABUS : 3.86 (-0.26%)
AMRN : 17.72 (+0.34%)
RUN : 15.45 (+1.25%)
RTRX : 21.30 (-1.21%)
TOCA : 10.91 (-0.55%)
BSTC : 71.52 (-0.14%)
Do Options Traders Know Something About Amarin (AMRN) Stock We Don't?

Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately.

AMRN : 17.72 (+0.34%)
New REDUCE-IT(TM) Trial Data Showing the Total Reduction in Ischemic Events Accepted for Presentation at the American College of Cardiology's 68th Annual Scientific Session

Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health, announced that new data showing the reduction in total major adverse cardiovascular (i.e., ischemic)...

AMRN : 17.72 (+0.34%)
Amarin (AMRN) Stock Up on Rumors of Acquisition by Pfizer

Amarin (AMRN) shares rally on rumors of its potential; acquisition by large pharmaceutical company, Pfizer. Speculations are rife about rising M&A activity in the pharma space.

CELG : 90.70 (+0.01%)
AMRN : 17.72 (+0.34%)
PFE : 42.60 (+0.47%)
BMY : 51.41 (-0.50%)
Thinking about buying stock in Amarin Corporation, Activision Blizzard, Netflix, Precipio or Tilray?

InvestorsObserver issues critical PriceWatch Alerts for AMRN, ATVI, NFLX, PRPO, and TLRY.

NFLX : 362.80 (+1.66%)
AMRN : 17.72 (+0.34%)
ATVI : 44.42 (-0.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade AMRN with:

Business Summary

Amarin Corporation plc is a global pharmaceutical group which develops innovative pharmaceutical products across a range of therapeutic areas utilizing its proprietary advanced oral and transdermal drug delivery technologies.

See More

Key Turning Points

2nd Resistance Point 18.02
1st Resistance Point 17.84
Last Price 17.72
1st Support Level 17.40
2nd Support Level 17.13

See More

52-Week High 23.33
Last Price 17.72
Fibonacci 61.8% 15.32
Fibonacci 50% 12.84
Fibonacci 38.2% 10.36
52-Week Low 2.35

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar